MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

[00:00:00] - [Speaker 0]
If you or someone you love was recently diagnosed with a liver condition, you know, you would naturally assume that your biggest health threat moving forward is liver failure.

[00:00:10] - [Speaker 1]
Right. That makes total sense.

[00:00:11] - [Speaker 0]
But you would actually be wrong. Yeah. The biggest threat to your life right now is actually a heart attack.

[00:00:16] - [Speaker 1]
I know, it sounds really alarming when you hear it put exactly that way. But, if you are sitting there right now feeling overwhelmed by a new medical diagnosis, I really want you to just take a deep breath.

[00:00:27] - [Speaker 0]
Yeah, exactly.

[00:00:28] - [Speaker 1]
We are speaking directly to you today to tell you that there is absolutely no need to panic, I mean it. The condition we are exploring in this deep dive is incredibly common and, well, importantly, it is Once you understand the actual mechanics of what is happening inside your body you will realize just how much power you have to fix it.

[00:00:49] - [Speaker 0]
That is the whole mission for this deep dive. We want to hand you a practical, optimistic toolkit. So we are going to explain the biology of your diagnosis, why it happens, and you know how to manage it.

[00:01:00] - [Speaker 1]
And I think to start it really helps to have a visual.

[00:01:03] - [Speaker 0]
Oh definitely. So I want you to picture the most efficient shipping and receiving warehouse in the entire world. This facility processes absolutely every single nutrient you consume.

[00:01:16] - [Speaker 1]
Every single one.

[00:01:18] - [Speaker 0]
And it carefully filters out every toxin you encounter. That warehouse is your liver. It is the ultimate logistics center of your body.

[00:01:26] - [Speaker 1]
That is a great way to look at it.

[00:01:27] - [Speaker 0]
But sometimes, you know, too many packages arrive at once. The system just gets backlogged and the condition we are talking about today is that backlog. It is called metabolic dysfunction associated Steatotic Liver Disease.

[00:01:40] - [Speaker 1]
Right, and doctors often use the acronym MASLD for that. You might also hear it referred to by its older name, which is, Non Alcoholic Fatty Liver Disease or NFLD.

[00:01:50] - [Speaker 0]
Just to be clear, are the exact same thing, right?

[00:01:52] - [Speaker 1]
Yes, they refer to the exact same condition. The medical community just updated the name recently to better reflect that this is fundamentally a metabolic issue.

[00:01:59] - [Speaker 0]
Okay, got it. So to fix the backlog in your internal warehouse, we first really need to understand what those extra packages are.

[00:02:06] - [Speaker 1]
Exactly. When we talk about MASLD, we are basically looking at the accumulation of triglycerides. Those are a specific type of fat and they are building up inside your actual liver cells.

[00:02:16] - [Speaker 0]
But the crucial part of the definition here is that this fat accumulation happens without the involvement of excess alcohol consumption because I mean the numbers on this are just staggering. Over twenty five percent of adults worldwide are dealing with this.

[00:02:31] - [Speaker 1]
It is everywhere.

[00:02:32] - [Speaker 0]
It really is. But I want to make sure we clarify a key distinction in the medical terminology because doctors sometimes call the early stage simple steatosis and then they call the more advanced stage MAH.

[00:02:44] - [Speaker 1]
Right. MAH.

[00:02:45] - [Speaker 0]
MAH stands for metabolic dysfunction associated steatohepatitis. So if we go back to our warehouse analogy, simple steatosis is like safely storing extra boxes in a spare room.

[00:02:55] - [Speaker 1]
Yeah, they are out of the way and not really bothering anyone.

[00:02:57] - [Speaker 0]
Exactly. But OMAH is a totally different story. That is when the sheer volume of boxes starts causing structural damage, like the boxes are catching fire.

[00:03:06] - [Speaker 1]
That is the perfect way to describe it. The medical world calls that damage inflammation. And over time that inflammation leads to scarring, which is known as fibrosis.

[00:03:17] - [Speaker 0]
Okay, so the simple fat storage is generally harmless on its own.

[00:03:20] - [Speaker 1]
Yes. The problem really only arises when the liver cells become so stuffed with fat that they get stressed out and inflamed. We want to prevent that inflammation.

[00:03:29] - [Speaker 0]
Wait, I'm stuck on something fundamental here though.

[00:03:31] - [Speaker 1]
What is it?

[00:03:32] - [Speaker 0]
If the liver is not genetically designed to store massive amounts of fat long term, why does it even accept the overflow at all? Like why doesn't it just let the triglycerides pass through the bloodstream and let our normal fat cells handle it?

[00:03:46] - [Speaker 1]
Well we do have normal fat cells designed for this and that brings us to the concept of insulin resistance.

[00:03:51] - [Speaker 0]
Right.

[00:03:52] - [Speaker 1]
We need to look at this on a cellular level for a second. Think of insulin as a key. Normally your fat cells have these little locks on their surface.

[00:04:00] - [Speaker 0]
Like literal padlocks.

[00:04:01] - [Speaker 1]
Basically, yeah. So when you eat, your pancreas releases insulin. That insulin acts as the key to open those locks and let fat and sugar inside for safe storage.

[00:04:11] - [Speaker 0]
Makes sense.

[00:04:12] - [Speaker 1]
But when we constantly over consume energy day after day, our fat cells get stuffed to their absolute maximum capacity.

[00:04:20] - [Speaker 0]
So they literally just run out of physical space?

[00:04:22] - [Speaker 1]
They do. And to protect themselves from bursting, the fat cells actually change their own locks. They down regulate their receptors so they completely stop listening to the insulin.

[00:04:31] - [Speaker 0]
Wow. So because the fat cells refuse to open up, the free fatty acids have nowhere to go.

[00:04:37] - [Speaker 1]
Exactly. They overflow and they just circulate freely in the stream. Now, the liver is this amazing adaptive biological filter. It sees all this highly reactive, dangerous fat floating around in the blood and it steps in to compensate for the failure of the fat cells.

[00:04:53] - [Speaker 0]
Oh, see.

[00:04:53] - [Speaker 1]
Yeah, it pulls those free fatty acids out of the blood and packs them into tiny lipid droplets inside its own cells. It is literally just trying to protect the rest of your body from having toxic fat levels in the blood.

[00:05:06] - [Speaker 0]
But it ends up taking on a burden it just cannot sustain.

[00:05:08] - [Speaker 1]
Precise.

[00:05:09] - [Speaker 0]
Well that paints a completely different picture. The liver is not failing at all. It is actually working overtime to save the rest of the body from a massive systemic metabolic crisis.

[00:05:19] - [Speaker 1]
It is the hero of the story really.

[00:05:22] - [Speaker 0]
But okay, if the liver is taking on all this extra fat, and especially if it reaches that MSH stage where it becomes inflamed, why doesn't it hurt? You would think a fire in the warehouse would cause some pain.

[00:05:33] - [Speaker 1]
You would think so, right. But the liver is a completely silent worker. The actual tissue of the liver, which we call the parenchyma, it completely lacks the nerve endings that register pain.

[00:05:45] - [Speaker 0]
None at all.

[00:05:45] - [Speaker 1]
Right. None inside the tissue itself. The only time you might feel discomfort is if the liver becomes enlarged it stretches the protective capsule surrounding it. That capsule does have nerves.

[00:05:55] - [Speaker 0]
Oh, okay.

[00:05:56] - [Speaker 1]
But for the vast majority of people, MASLD goes totally underdiagnosed because it rarely causes any symptoms early on, So doctors have to act as detectives to find the backlog before it causes severe scarring.

[00:06:08] - [Speaker 0]
And they usually start that detective work by looking at liver enzymes on a routine blood test?

[00:06:12] - [Speaker 1]
Yes, exactly.

[00:06:14] - [Speaker 0]
You might see them listed on your lab report as ALT and AST. When liver cells get stressed or damaged by too much fat, their cell walls break open and they literally leak these enzymes into the bloodstream.

[00:06:25] - [Speaker 1]
That is a great explanation.

[00:06:27] - [Speaker 0]
I tend to think of those enzymes as the smoke alarms in the warehouse. If the smoke alarm goes off on your blood test, the doctor knows there is a problem. But you know, if the liver is a silent worker, what happens if the smoke alarms fail to go off?

[00:06:42] - [Speaker 1]
That is a really important question.

[00:06:44] - [Speaker 0]
Like, can you have a massive fat backlog with You totally normal enzyme

[00:06:49] - [Speaker 1]
absolutely can. You can have MA SLD and even the active inflammation of MA ish with completely normal litter enzymes.

[00:06:56] - [Speaker 0]
Wait, really?

[00:06:57] - [Speaker 1]
Yes. The smoke alarms only catch active rapid cell death. They do not always catch a slow smoldering inflammation.

[00:07:05] - [Speaker 0]
Well if the basic blood test is not reliable, how do doctors actually figure out what is going on without performing an invasive biopsy?

[00:07:12] - [Speaker 1]
Right, nobody wants a biopsy if they can avoid it. So they rely on scoring algorithms to get wider view of your metabolic health. The most common tool right now is called the FIB4 index. It takes your age, your AST and ALT enzyme levels, and your platelet count, and it runs them all through a mathematical formula.

[00:07:29] - [Speaker 0]
So it is just a calculation?

[00:07:32] - [Speaker 1]
Gives your doctor a statistical risk score for having advanced liver scarring. If that FIB4 score comes back high, the next step is usually a specialized ultrasound. It is called a Fibro Scan.

[00:07:44] - [Speaker 0]
I think the technical term is vibration controlled transient elastography. Which is quite a mouthful.

[00:07:50] - [Speaker 1]
It really is, which is why we just say Fibro Scan.

[00:07:53] - [Speaker 0]
My favorite way to explain the Fibro Scan to people is to think about being at the grocery store.

[00:07:58] - [Speaker 1]
Oh I love this analogy!

[00:07:59] - [Speaker 0]
Right, so when you want to know if an avocado is ripe, you give it a gentle squeeze or if you want to check a watermelon, you tap it to hear how it sounds. You are checking the internal firmness without having to actually cut the fruit open.

[00:08:11] - [Speaker 1]
Exactly!

[00:08:11] - [Speaker 0]
And a FibroScan does the exact same thing to your liver just using sound waves. It sends a gentle mechanical pulse into the liver and measures how fast the sound wave dances back.

[00:08:21] - [Speaker 1]
Right, because a healthy liver is soft and squishy, so the wave moves slowly.

[00:08:25] - [Speaker 0]
But a liver with fibrosis scarring is stiff, meaning the sound wave bounces back very quickly.

[00:08:31] - [Speaker 1]
It is a brilliant piece of technology honestly. It is completely painless, it takes about five minutes in the clinic and it provides a super clear map of structural damage.

[00:08:41] - [Speaker 0]
That is amazing.

[00:08:42] - [Speaker 1]
It is. But what is truly fascinating is where this diagnostic field is heading next. Researchers are currently developing machine learning models that do not even need an ultrasound to predict severe scarring.

[00:08:55] - [Speaker 0]
Really? How does that work?

[00:08:57] - [Speaker 1]
These computer models analyze subtle longitudinal patterns in your routine electronic health records over several years.

[00:09:04] - [Speaker 0]
So they're looking for patterns that a human doctor might just miss?

[00:09:07] - [Speaker 1]
Precisely. By tracking microscopic fluctuations in your routine blood work and vital signs over time, these artificial intelligence models are predicting liver cirrhosis up to two years before it actually happens.

[00:09:19] - [Speaker 0]
Up two years?

[00:09:20] - [Speaker 1]
Yeah, they flag patients for intervention long before the standard smoke alarms ever go off.

[00:09:24] - [Speaker 0]
Okay. Well, if we can detect it earlier, we really need to know who is most at risk. We know the major risk factors are type two diabetes, obesity, and metabolic syndrome.

[00:09:34] - [Speaker 1]
Right.

[00:09:34] - [Speaker 0]
But I think a lot of people stereotype liver fat as strictly a weight issue. Like the assumption is that if you are thin, your liver is perfectly healthy. Is that actually true?

[00:09:44] - [Speaker 1]
It is a really dangerous misconception actually. Between ten and twenty percent of people diagnosed with MSLD are considered lean by traditional body mass index standards.

[00:09:54] - [Speaker 0]
Wait, twenty percent?

[00:09:55] - [Speaker 1]
Up to twenty percent, yes. Because this is a metabolic disease, not a body shaped disease. A person can appear totally thin on the outside but still carry deep visceral fat around their internal organs.

[00:10:07] - [Speaker 0]
Or they can have a genetic predisposition, right?

[00:10:09] - [Speaker 1]
Exactly. Genetics play a huge role.

[00:10:10] - [Speaker 0]
What kind of genetics are we talking about here?

[00:10:12] - [Speaker 1]
There is a very specific gene variant called PNPLA3. This gene is responsible for creating a protein that breaks down triglycerides in the liver. If you inherit a mutated version of this gene, that protein just does not function correctly. Your liver simply becomes a magnet for storing fat completely regardless of your diet or your weight.

[00:10:32] - [Speaker 0]
That is so unfair honestly.

[00:10:34] - [Speaker 1]
It is tough. And because of genetics and generally rising rates of metabolic syndrome pediatricians are actually now screening high risk children between the ages of nine and 11.

[00:10:44] - [Speaker 0]
Wow that young.

[00:10:45] - [Speaker 1]
Yes. They are looking for subtle enzyme elevations specifically they look for ALT levels above 22 for girls and 26 for boys.

[00:10:53] - [Speaker 0]
Okay, if this disease is so systemic that brings us right back to that provocative fact we started with the beginning of the deep dive.

[00:11:00] - [Speaker 1]
The heart connection.

[00:11:00] - [Speaker 0]
Yes, If heart disease is the actual threat here, then just monitoring liver enzymes is clearly not enough. We have to actively stop the metabolic fire. How exactly does a backlogged liver cause a heart attack?

[00:11:13] - [Speaker 1]
Well, liver and the heart are intimately connected by the bloodstream. When the liver is stuffed with fat and actively inflamed, it starts pumping inflammatory cytokines directly into the blood.

[00:11:23] - [Speaker 0]
So it is sending out alarm signals.

[00:11:25] - [Speaker 1]
Exactly. And at the same time, because the liver is so overwhelmed by all those free fatty acids we talked about, it starts packaging them into dangerous cholesterol particles. These are called VLDL.

[00:11:36] - [Speaker 0]
Okay, VLDL.

[00:11:37] - [Speaker 1]
These particles circulate through your body, they become oxidized, and they embed themselves directly into the walls of your arteries. So the metabolic fire in the liver literally spills over and damages the blood vessels of your heart.

[00:11:51] - [Speaker 0]
So when a doctor hands you a plan to manage your liver, they're actually handing you a strategy to save your heart.

[00:11:57] - [Speaker 1]
That is exactly

[00:11:58] - [Speaker 0]
Knowing that, what are the actionable tools in the management toolkit? So let's get into the practical stuff.

[00:12:03] - [Speaker 1]
I love this part. The absolute most powerful tools in your toolkit are lifestyle modifications. The clinical data on this incredibly encouraging.

[00:12:12] - [Speaker 0]
Okay, lay it on us.

[00:12:13] - [Speaker 1]
It all comes down to gradual sustained weight loss for those who are overweight. If you lose just 5% of your total body weight, you significantly reduce the amount of fat stored in the liver.

[00:12:24] - [Speaker 0]
Wait, let us pause on that. Losing just 5% of your body weight triggers the liver to actually dump its stored fat. Just 5%.

[00:12:30] - [Speaker 1]
Just 5%. The body recognizes the calorie deficit and starts pulling energy right out of the liver's storage droplets.

[00:12:37] - [Speaker 0]
That is amazing.

[00:12:38] - [Speaker 1]
It gets better. If you can push that to 7% weight loss, you actually resolve the inflammation. You completely stop the active damage of MSH. Wow. And if you reach 10% weight loss, the liver will actually begin to heal its own structural tissue and reverse the fibrosis scarring.

[00:12:55] - [Speaker 0]
Okay, that is honestly the most hopeful thing we have discussed so far. The liver can heal its own scars. It

[00:13:01] - [Speaker 1]
is an incredible organ.

[00:13:02] - [Speaker 0]
But how do we actually achieve that 10%? Like what is this specific dietary strategy?

[00:13:07] - [Speaker 1]
The clinical guidelines heavily favor a hypocaloric Mediterranean diet.

[00:13:12] - [Speaker 0]
Hypo caloric just meaning a calorie deficit, right?

[00:13:14] - [Speaker 1]
Right. Operating at a slight calorie deficit while eating a diet that is really rich in vegetables, lean proteins, and healthy fats like olive oil.

[00:13:22] - [Speaker 0]
But I want to dig into the specifics of what we need to avoid. Sugar is obviously bad, but I have read that fructose is particularly damaging to the liver. Why is fructose worse than normal glucose?

[00:13:33] - [Speaker 1]
Ah, this is a crucial biological mechanism to understand. When you consume glucose, which is just basic carbo hydrate energy, your entire body can use it. Your brain, your muscles, your heart, they all pull glucose out of the blood to use for fuel. Okay. But fructose is completely different.

[00:13:53] - [Speaker 1]
The vast majority of the cells in your body just do not have the enzyme required to break down fructose.

[00:13:58] - [Speaker 0]
Oh, where does it go?

[00:13:59] - [Speaker 1]
It goes straight to the liver. The liver is literally the only organ equipped to process it.

[00:14:03] - [Speaker 0]
Oh, wow.

[00:14:04] - [Speaker 1]
And furthermore, the specific enzyme in the liver that breaks down fructose does not have an off switch.

[00:14:10] - [Speaker 0]
What do you mean by an off switch?

[00:14:11] - [Speaker 1]
Well, with normal glucose, once a cell has enough energy, it signals the body to stop processing it. It says, hey, we are full. But fructose bypasses that regulatory system entirely.

[00:14:22] - [Speaker 0]
That sounds dangerous.

[00:14:23] - [Speaker 1]
It is. If you drink a massive soda sweetened with high fructose corn syrup, that liquid fructose hits your liver like a fire hose. The liver has absolutely no choice but to rapidly convert all that excess fructose directly into triglycerides. It is essentially a direct fat delivery system.

[00:14:39] - [Speaker 0]
So commercially produced fructose, especially in liquid form like soda, just has to be eliminated from the diet?

[00:14:45] - [Speaker 1]
Completely eliminated if possible.

[00:14:47] - [Speaker 0]
What about alcohol? If a patient has non alcoholic fatty liver disease, can they still have, you know, a glass of wine with dinner?

[00:14:56] - [Speaker 1]
Alcohol really must be severely restricted and ideally eliminated entirely.

[00:15:01] - [Speaker 0]
Even though the disease is non alcoholic.

[00:15:03] - [Speaker 1]
Right, even though alcohol did not cause the initial fat buildup, processing alcohol creates toxic byproducts. If your liver is already struggling with insulin resistance and inflammation, forcing it to also process a toxin like alcohol is simply asking too much. It just accelerates the scar process.

[00:15:20] - [Speaker 0]
That makes total sense. Do not kick the warehouse when it is already on fire. Exactly. Okay. So we have covered the diet.

[00:15:26] - [Speaker 0]
Now we need to talk about movement. How does exercise specifically help a backlogged liver?

[00:15:32] - [Speaker 1]
The current medical recommendation is a hundred and fifty to three hundred minute of moderate aerobic exercise a week. And the reason this works so beautifully comes right back to insulin resistance.

[00:15:42] - [Speaker 0]
Okay.

[00:15:42] - [Speaker 1]
Remember those rusty locks on the fat cells we talked about earlier?

[00:15:45] - [Speaker 0]
Yes, where the cells refuse to open up and accept energy.

[00:15:49] - [Speaker 1]
Well, when you actively contract your muscles during exercise, those muscle cells require immediate energy. And through this amazing biological workaround, working muscles can actually pull glucose and free fatty acids out of the bloodstream without needing insulin at all.

[00:16:04] - [Speaker 0]
Wait, they bypass the insulin key entirely?

[00:16:06] - [Speaker 1]
They do! The physical contraction forces energy transport proteins to the surface of the muscle cell. By exercising, your muscles act like a massive sponge. They are just soaking up the excess energy before it ever has a chance to reach the liver.

[00:16:20] - [Speaker 0]
So the muscles intercept the packages before they reach the warehouse.

[00:16:24] - [Speaker 1]
That is exactly what happens.

[00:16:25] - [Speaker 0]
That makes perfect sense. But you know, diet and exercise are just not enough. Like if someone has a severe genetic predisposition or the scarring is already quite advanced, what is inside the medical side of the toolkit?

[00:16:38] - [Speaker 1]
For patients with a body mass index over thirty five who are dealing with severe metabolic complications, bariatric surgery is an incredibly effective tool.

[00:16:46] - [Speaker 0]
Really? Surgery for the liver?

[00:16:48] - [Speaker 1]
Yes. By altering the digestive anatomy, the surgery fundamentally resets the patient's metabolic hormones. This leads to rapid improvement in liver health, and it can actually halt the progression of MNSH entirely.

[00:17:01] - [Speaker 0]
That's powerful. Yeah. But I think the question every patient really wants to know is about medication. Like, is there a magic pill you can take to clear the fat?

[00:17:10] - [Speaker 1]
Well, there is no single magic pill just yet, but the landscape of treatment is evolving so rapidly. It is incredibly optimistic. First, we have a class of medications called GLP-one receptor agonists.

[00:17:23] - [Speaker 0]
Oh, I have heard of these. You might recognize them by names like simaglutide or liraglutide. Those are the medications originally developed for diabetes that have recently become super famous for weight loss.

[00:17:34] - [Speaker 1]
Exactly. GLP-one stands for Glucagon like Peptide one. These medications mimic a naturally occurring hormone that regulates appetite and a blood sugar.

[00:17:43] - [Speaker 0]
Okay.

[00:17:43] - [Speaker 1]
They obviously help patients achieve that critical 10% weight loss we talked about, which naturally unburdens the liver. But clinical trials are showing something else. GLP-one receptors also exist in the liver itself.

[00:17:55] - [Speaker 0]
Oh, fascinating.

[00:17:56] - [Speaker 1]
Yeah, the medication seems to actively reduce inflammatory pathways inside the liver tissue, directly resolving MASH and stopping the progression of scarring.

[00:18:06] - [Speaker 0]
So it reduces the systemic fat burden, but it also directly calms the inflammation right at the source in the liver. Exactly. What other medications are doctors using right now?

[00:18:15] - [Speaker 1]
For certain non diabetic adults who have a confirmed biopsy showing MAH, doctors sometimes prescribe high doses of vitamin E, specifically eight hundred international units daily.

[00:18:25] - [Speaker 0]
Why vitamin E? What is the biological mechanism there?

[00:18:28] - [Speaker 1]
It comes down to oxidative stress. When the liver is packed with fat and inflamed, the cells undergo these chaotic chemical reactions that release free radicals.

[00:18:37] - [Speaker 0]
And free radicals are bad?

[00:18:38] - [Speaker 1]
Very bad. They bounce around inside the cell damaging DNA and degrading the cell walls. This is oxidative stress. Vitamin E is a potent antioxidant so it neutralizes those free radicals, essentially acting as a chemical shield that calms the inflammation and protects the cells from dying.

[00:18:54] - [Speaker 0]
That is a really fascinating mechanism.

[00:18:56] - [Speaker 1]
It is highly effective for the right patient. Though I have to say, high doses of vitamin E do carry their own risks and they must be managed carefully by a physician.

[00:19:06] - [Speaker 0]
Of course.

[00:19:06] - [Speaker 1]
Beyond that, the future is incredibly bright. There are several new highly targeted medications currently moving through clinical trials and FDA approvals. These drugs are designed to target specific hormone receptors in the liver to directly block the creation of norfat and they actively dismantle existing scar tissue. The medical cavalry is truly on the way.

[00:19:28] - [Speaker 0]
Well that brings us to a perfect summary of this deep dive. If you are listening to this right now, we really want you to leave with clarity and hope. MASD is incredibly common and because the liver lacks pain receptors, it is often totally silent. But more importantly, it is highly treatable. The liver is the most forgiving, resilient, regenerative organ in your entire body.

[00:19:48] - [Speaker 0]
If you lower the metabolic burden, the liver will heal itself.

[00:19:51] - [Speaker 1]
I really want to reinforce that message. You are in the driver's seat here. By adopting a Mediterranean diet, eliminating liquid fructose, using your muscles to soak up excess energy, and partnering with your doctor to utilize the latest medical tools, you have absolutely everything you need to manage this condition. Your body wants to find balance again.

[00:20:11] - [Speaker 0]
I love that. Before we wrap up, I leave you with a final provocative thought to mull over. Something we haven't even touched on yet. Could the future of treating liver disease lie entirely outside the liver itself?

[00:20:23] - [Speaker 1]
Oh, is such a cool area of research.

[00:20:25] - [Speaker 0]
Right. Emerging science is showing us that our gut microbiome, which is the massive colony of bacteria living in our digestive tract, communicates directly with the liver.

[00:20:35] - [Speaker 1]
And because the gut and the liver share a direct massive blood supply called portal vein, they are constantly in chemical conversation.

[00:20:42] - [Speaker 0]
Exactly. So in the very near future, reversing liver fat might not just be about eating less sugar or taking a liver specific medication. It might be as simple as taking a specialized targeted probiotic to change the bacterial environment in your gut.

[00:20:57] - [Speaker 1]
It is wild to think about.

[00:20:58] - [Speaker 0]
But by changing the gut, can send completely new, metabolic instructions straight through the portal vein to the warehouse. So until that future arrives, be kind to your liver. Use the tools we discussed today to clear out the backlog and trust that your body knows exactly how to heal.